Skip to main content
Home
Latest news
Browse topics
Lupus Rheumatoid arthritis Spondyloarthropathies COVID-19 Browse all topics
In focus
Bimekizumab: Dual IL-17A/IL-17F inhibition in SpA Anifrolumab for the treatment of SLE JAK inhibitor safety: Weighing up the data and understanding the risks Rituximab and rheumatology practice in the COVID-19 era Safety snapshot: Upadacitinib in patients with PsA Repurposing rheumatology drugs for COVID-19 Telemedicine in rheumatology: COVID-19 and beyond Managing PsA in resource-limited settings
Conferences
ACR Convergence 2022 EULAR 2022 Congress
About us
Medicine Matters Rheumatology
EXTENDED SEARCH

06-06-2020 | EULAR 2020 | Conference coverage | Video

Researcher comment: COVID-19 risk factors in RMD patients

Pedro Machado discusses data from the COVID-19 Global Rheumatology Alliance registry on the risk factors for COVID-19 hospitalization in patients with rheumatic and musculoskeletal diseases (9:30).

External Content

Click Play to display this content and agree to third party cookies. (>)

Update your current cookie settings.

Read the transcript

Related content

06-06-2020 | EULAR 2020 | Conference coverage | News

COVID-19 hospitalization: What do the data tell us?

18-05-2020 | COVID-19 | News

Corticosteroid use may be a risk factor for COVID-19 hospitalization in rheumatic disease patients

01-04-2020 | COVID-19 | Podcast | Article

The COVID-19 Global Rheumatology Alliance registry: What you need to know
Image Credits